Avanos Medical Inc

Análisis de la acción Avanos Medical Inc (AVNS)

$24.990

+0.010 (+0.04%)Al cierre

Loading chart…
High
25.000
Open
24.980
VWAP
24.99
Vol
2.08M
Mkt Cap
899.72M
Low
24.980
Amount
51.87M
EV/EBITDA, TTM
15.68

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes Nexus TKO, an anti-reflux needleless connector technology. The Pain Management and Recovery is a portfolio of non-opioid pain solutions including surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems, as well as Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

avanos.com

Métricas de valoración

The current forward P/E ratio for Avanos Medical Inc (AVNS) is 30.67, compared to its 5-year average forward P/E of 16.96.

Forward P/E

Strongly Overvalued
5Y Average P/E
16.96
Current P/E
30.67
Sobrevalorada
22.56
Infravalorada
11.35

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.94
Current EV/EBITDA
15.68
Sobrevalorada
16.55
Infravalorada
-2.66

Forward P/S

Fair
5Y Average P/S
1.36
Current P/S
1.58
Sobrevalorada
1.75
Infravalorada
0.97

Alphio AI Price Scenarios for AVNS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AVNS

$14.34

Precio del escenario

B

Base

Base · 50%AVNS

$12.98

Precio del escenario

B

Bear

Bear · 25%AVNS

$12.89

Precio del escenario

Whales holding AVNS

B

Blackhill Capital, Inc

+ HoldingAVNS

+14.48%

3M Return

Cronología de eventos

2026-07-27 (ET)

10:00:00

American Industrial Partners Acquires Avanos Medical for Approximately $1.272B

2026-07-20 (ET)

17:30:00

American Industrial Partners Acquires Avanos Medical

2026-07-02 (ET)

10:30:00

Avanos Medical and AIP to Complete Acquisition

2026-04-14 (ET)

16:20:00

Major Averages Rise on Renewed U.S.-Iran Diplomacy Optimism

12:00:00

Major U.S. Averages Broadly Higher, Nasdaq Up 1.66%

Noticias

AVNS FAQ — answered by Alphio AI

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes Nexus TKO, an anti-reflux needleless connector technology. The Pain Management and Recovery is a portfolio of non-opioid pain solutions including surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems, as well as Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis